Literature DB >> 10100687

What is the role of obesity in hypertension and target organ injury in African Americans?

D W Jones1.   

Abstract

Hypertension is the most common reversible risk factor for cardiovascular disease. It is especially common in African Americans. One of the factors that may contribute to the high rates of hypertension and target organ injury in African Americans is obesity. Hypertension and obesity are common among African Americans. Obesity is particularly common in African American women. About 75% of African American women are obese. Regulation of both body weight and blood pressure are complex, involving an interaction of genetic and environmental factors. Most research thus far has focused on blood pressure control systems studied in other forms of hypertension, including the sympathetic nervous system, the renin angiotensin system, and metabolic factors-primarily insulin resistance. Proposed mechanisms that are unique to obesity-associated hypertension include: 1) intrarenal physical forces associated with obesity-induced changes in the renal medulla; 2) genetic/metabolic factors; and 3) metabolic effects of abdominal visceral fat. The Jackson Heart Study provides a unique opportunity to address unresolved questions in the relationship of body weight, blood pressure, and cardiovascular disease.

Entities:  

Mesh:

Year:  1999        PMID: 10100687     DOI: 10.1097/00000441-199903000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  9 in total

1.  Cardiovascular disease in African-American women: a dilemma of culture.

Authors:  G C Dennis
Journal:  J Natl Med Assoc       Date:  1999-06       Impact factor: 1.798

2.  What factors hinder women of color from obtaining preventive health care?

Authors:  Llewellyn J Cornelius; Pamela L Smith; Gaynell M Simpson
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

3.  Diastolic wall strain is associated with incident heart failure in African Americans: Insights from the atherosclerosis risk in communities study.

Authors:  Daisuke Kamimura; Takeki Suzuki; Michael E Hall; Wanmei Wang; Michael D Winniford; Amil M Shah; Carlos J Rodriguez; Kenneth R Butler; Thomas H Mosley
Journal:  J Cardiol       Date:  2017-12-06       Impact factor: 3.159

4.  Physical Activity Is Associated With Reduced Left Ventricular Mass in Obese and Hypertensive African Americans.

Authors:  Daisuke Kamimura; Paul D Loprinzi; Wanmei Wang; Takeki Suzuki; Kenneth R Butler; Thomas H Mosley; Michael E Hall
Journal:  Am J Hypertens       Date:  2017-06-01       Impact factor: 2.689

5.  Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study.

Authors:  Daisuke Kamimura; Takeki Suzuki; Wanmei Wang; Matthew deShazo; John E Hall; Michael D Winniford; Iftikhar J Kullo; Thomas H Mosley; Kenneth R Butler; Michael E Hall
Journal:  Hypertens Res       Date:  2018-06-15       Impact factor: 3.872

Review 6.  Kidney disease in African Americans: genetic considerations.

Authors:  Deborah A Price; Errol D Crook
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

Review 7.  Physiology, genetics, and cardiovascular disease: focus on African Americans.

Authors:  Gary H Gibbons
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738

8.  Renal cell cancer among African Americans: an epidemiologic review.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

9.  The impact of obesity on hypertension and diabetes control following healthy Lifestyle Intervention Program in a developing country setting.

Authors:  Aliakbar Tavassoli; Mojgan Gharipour; Nafiseh Toghianifar; Nizal Sarrafzadegan; Alireza Khosravi; Behzad Zolfaghari; Sonia Zarfeshani
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.